临床药师应用PDCA循环法在内分泌科住院医嘱审核干预中的实践Practice of Clinical Pharmacists Using PDCA Cycle Management in the Review and Intervention of the Inpatient Medical Order in the Endocrinology Department
肖晓,林璐,陈志江,曾英彤,赖伟华,劳海燕
XIAO Xiao,LIN Lu,CHEN Zhijiang,ZENG Yingtong,LAI Weihua,LAO Haiyan
摘要(Abstract):
目的探索内分泌科临床药师开展住院医嘱审核干预的思路和方法,为促进合理用药提供参考。方法运用PDCA(Plan-Do-Check-Action)循环管理法对内分泌科住院医嘱进行审核和干预,对管理前后不合理医嘱的情况进行对比,总结和分析效果,探讨医嘱审核思路,将管理流程标准化。结果通过PDCA循环管理法干预后,内分泌科住院医嘱不合格率从3.09%下降到1.01%,未针对患者肾功能遴选药物和调整剂量的不合格医嘱从10例次下降到了2例次,干预接受率从90.00%上升到了100.00%,本次干预达到了预期的目标值。结论专科临床药师应用PDCA循环管理法在住院病区进行医嘱审核和干预,是促进合理用药的重要实践,为医院促进合理用药的管理提供了一个切实可行的途径。
OBJECTIVE To explore the ideas and methods of clinical pharmacists in the endocrinology to carry out review and intervention of inpatient medical orders,and to provide reference for promoting rational drug use.METHODS The PDCA(Plan-DoCheck-Action) cycle management was used to review and intervene inpatients medical orders in the endocrinology.The situations of unreasonable medical orders before and after management were compared,and then the effects were summarized and analyzed.The ideas of medical orders' review were explored,and the management processes were standardized.RESULTS After intervention by PDCA cycle management,the rate of unreasonable medical orders decreased from 3.09% to 1.01%.The number of unreasonable medical orders that doctors did not respond to renal function selection and adjusted doses decreased from 10 to 2 cases.Intervention acceptance rate increased from 90.0% to 100.0%.This intervention reached the expected target value.CONCLUSION It is an important practice to promote rational drug use that the specialist clinical pharmacists use the PDCA cycle management method to review and intervene medical orders in inpatient wards,which provides a practical way for hospitals to promote rational drug management.
关键词(KeyWords):
PDCA循环法;医嘱审核;处方审核;干预;内分泌科
PDCA cycle management;medical orders review;prescription review;intervention;endocrinology
基金项目(Foundation): 国家自然科学基金(81903652);; 广东省医院药学研究基金(2018LR02;2018HS01)
作者(Author):
肖晓,林璐,陈志江,曾英彤,赖伟华,劳海燕
XIAO Xiao,LIN Lu,CHEN Zhijiang,ZENG Yingtong,LAI Weihua,LAO Haiyan
参考文献(References):
- [1]国家卫生健康委员会办公厅,国家中医药管理局办公室,中央军委后勤保障部办公厅.医疗机构处方审核规范(国卫办医发〔2018〕14号)[Z]. 2018-06-29.
- [2]潘姝,原永芳金剑.临床药师参与心血管内科临床治疗实践的回顾性研究及思路探讨[J].中国现代应用药学,2019,36(10):1260-1263.
- [3]傅昌芳,陈昭琳,沈爱宗.临床药师实施医嘱审核对不合理医嘱干预效果分析[J].中南药学,2018,16(10):1446-1449.
- [4]张伶俐,张扬,曾力楠,等.美国临床药师的工作职责及定位[J].中国药房,2016,27(34):4753-4756.
- [5]任真年.现代医院医疗质量管理[M].北京:人民军医出版社,2002:65-70.
- [6]阚全程.PDCA循环在医院战略管理中的运用[J].中国医院管理,2009,29(8):47-49.
- [7]刘玲,李春梅,杨晓丽,等.PDCA循环在提高医院感染管理质量中的效果分析[J].中华医院感染学杂志,2017,27(3):685-687.
- [8]赵建军.PDCA护理模式在小儿支气管肺炎中的应用效果及优势分析[J].中国实用医药,2019,14(24):142-144.
- [9]马佩杰,马聪,马俊强,等.戴明循环管理法在降低自动化药房快速出药系统出药差错率中的应用[J].中国医院药学杂志,2016,36(15):1323-1326.
- [10]潘慧,张渊,朱蓓琳,等.消化科围操作期预防用药中实施PDCA模式质量管理[J].世界临床药物,2019,40(2):143-146.
- [11]中华人民共和国卫生部.医院处方点评管理规范(试行)(卫医管发〔2010〕28号)[Z]. 2010-02-10.
- [12]中华人民共和国药品管理法(2019年国家主席令第31号)[Z].2019-08-26.
- [13]刘世坤.湖南省处方审核实施细则[J].中南药学,2020,17(6):801-805.
- [14]胡展红,邱晓燕.肾内科临床药师开展医嘱审核的思维模式初探[J].中国药房,2017,28(20):2862-2864.
- [15]陈芳超,刘金泳,邱素君,等.临床药师在肾内科开展医嘱审核思路的探讨[J].中国合理用药探索,2018,15(4):64-66.
- [16]李振东,王丽,安俊军,等.临床药师对3种清洁手术围术期预防使用抗菌药物持续干预的效果评价[J].今日药学,2018,28(7):479-482,489.
- [17]赵紫楠,纪立伟,胡欣,等.内分泌科临床药师有效工作方法的探索与效果评价[J].临床药物治疗杂志,2017,15(12):15-18.
- [18]张永文,张梅琴,张冉,等.行政干预对综合性医院抗菌药物合理使用的探讨[J].中国病案,2013,14(6):32-33.
- [19]曹媛,邓蓉蓉,孙萍萍.临床药师参与辅助用药的医嘱审核及干预的效果分析[J].今日药学,2017,27(4):271-273.
- [20]饶媚,赖小卿,蒋建清.我院辅助用药使用情况及其超说明书用药医嘱审核与干预[J].海峡药学,2017,29(9):79-84.
- [21]朱江华,李玲,汤卓红,等.PDCA循环在我院Ⅰ类切口手术抗菌药物预防使用中的应用[J].广东药科大学学报,2019,35(4):561-564.
- PDCA循环法
- 医嘱审核
- 处方审核
- 干预
- 内分泌科
PDCA cycle management - medical orders review
- prescription review
- intervention
- endocrinology